Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product

Archives of Pharmacal Research

Volumn 33, Issue 7, 2010, Pages 1009-1017

  Alsarra, Ibrahim A ^a,b   Alanazi, Fars K ^a   Ahmed, Sayed M ^a   Bosela, Ahmed A ^a   Alhamed, Suliman S ^a   Mowafy, Hammam A ^a   Neau, Steven H ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Co evaporation method; Hydroxypropyl CD; Itraconazole; Polyvinylpyrrolidone; Solid inclusion complexation

Indexed keywords

CYCLODEXTRIN; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPASILOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG FORMULATION; DRUG RELEASE; DRUG SENSITIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DOSAGE FORMS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 77955405495     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0706-3     Document Type: Article

References (51)

1. M. O. Ahmed I. El-Gibaly S. M. Ahmed 1998 Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole Int. J. Pharm. 171 111 121 10.1016/S0378-5173(98)00163-X 1:CAS:528:DyaK1cXlsVyitbc%3D (Pubitemid 28410252)
2. F. K. Alanazi S. M. Ahmed S. S. Alhamed H. A. Mowafy I. A. Alsarra M. A. Bayomi 2007 Inclusion complexation of Itraconazole with cyclodextrin derivatives: phase solubility and physicochemical characterization Mansoura J. Pharm. Sci. 23 177 194 1:CAS:528:DC%2BD1cXntlShs7s%3D
3. A. H. Al-Marzouqi H. M. Elwy I. Shehadi A. Adem 2009 Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques J. Pharm. Biomed. Anal. 49 227 233 10.1016/j.jpba.2008.10.032 1:CAS:528:DC%2BD1MXhs1amu7k%3D 19062214
4. M. A. Al-Meshal M. A. Ramadan K. M. Lotfi A. M. Shibl 1995 Determination of meropenem in plasma by high performance liquid chromatography and a microbioloical method J. Clin. Pharm. Ther. 20 159 163 10.1111/j.1365-2710.1995. tb00642.x 1:CAS:528:DyaK2MXmvFOjsLk%3D 7593377
5. I. A. Alsarra F. K. Alanazi S. S. Alhamed S. M. Ahmed H. A. Mowafy 2007 Preparation and evaluation of itraconazole-cyclodextrin complexes in solid state Alex. J. Pharm. Sci. 21 47 55 1:CAS:528:DC%2BD2sXmsVGktLs%3D
6. G. L. Amidon H. Lennernäs V. P. Shah J. R. Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 413 420 10.1023/A:1016212804288 1:CAS:528:DyaK2MXksVGqur8%3D 7617530
7. H. O. Ammar H. A. Salama M. Ghorab A. A. Mahmoud 2006 Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy Int. J. Pharm. 320 53 57 10.1016/j.ijpharm.2006.04.002 1:CAS:528:DC%2BD28XnsFCqur8%3D 16701974 (Pubitemid 44128703)
8. F. Ancarani 1993 Incidence and prevalence of Candida nonalbicans in oral Candida infections Clinician 11 6 10
9. Aulton, M. E., Pharmaceutics: The Science of Dosage Form Design. New York, USA, (1988).
10. Banker, G. S., Anderson, N. R., Tablets, In Lachman, L., Liberman, H. A., and Kanig, J. I. (Eds.), The Theory and Practice of Industrial Pharmacy. Lea and Febiger, Philadelphia, pp. 293-345, (1986).
11. G. P. Bettinetti P. Mura A. Liguori G. Bramanti F. Giordano 1988 Solubilization and interaction of naproxen with cyclodextrins in aqueous solution and in the solid state Farmaco Prat. 43 331 343 1:CAS:528: DyaL1MXht1WhtLc%3D 3243349 (Pubitemid 19016182)
12. M. E. Brewster R. Vandecruys J. Peeters P. Neeskens G. Verreck T. Loftsson 2008 Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutyletherbeta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions Eur. J. Pharm. Sci. 34 94 103 10.1016/j.ejps.2008.02.007 1:CAS:528:DC%2BD1cXms1WgsL0%3D 18420390
13. B. Cappello G. De Rosa L. Giannini M. I. La Rotonda G. Mensitieri A. Miro F. Quaglia R. Russo 2006 Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: Potential as buccal delivery system Int. J. Pharm. 319 63 70 10.1016/j.ijpharm.2006.03.031 1:CAS:528: DC%2BD28XmvFKns7Y%3D 16650700 (Pubitemid 44069630)
14. M. Cirri F. Maestrelli G. Corti S. Furlanetto P. Mura 2006 Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization J. Pharm. Biomed. Anal. 42 126 131 10.1016/j.jpba.2005.11.029 1:CAS:528:DC%2BD28Xosl2mtLs%3D 16406448 (Pubitemid 44403897)
15. K. De Beule J. V. Gestel 2001 Pharmacology of itraconazole Drugs 61 27 37 10.2165/00003495-200161001-00003 11219548
16. B. Dupont E. Drouhet 1987 Early experience with itraconazole in vitro and in patients: Pharmacokinetic studies and clinical results Rev. Infect. Dis. 9 S71 S76 3027850
17. H. A. El-Maradny S. A. Mortada O. A. Kamel A. H. Hikal 2008 Characterization of ternary complexes of meloxicam-HP β CD and PVP or L-arginine prepared by the spray-drying technique Acta Pharm. 58 455 466 10.2478/v10007-008-0029-9 1:CAS:528:DC%2BD1MXlsFChsw%3D%3D 19103579
18. A. Espinel-Ingroff S. Shadomy R. J. Gebhart 1984 In vitro studies with R 51,211 (Itraconazole) Antimicrob. Agents Chemother. 26 5 9 1:CAS:528: DyaL2cXlt1KltLs%3D 6089654
19. E. Farmaki J. Evdoridou T. Pouliou E. Bibashi P. Panagopoulou J. Filioti A. Benos D. Sofianou G. Kremenopoulos E. Roilides 2007 Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections Am. J. Perinatol. 24 127 135 10.1055/s-2007-970078 17304423 (Pubitemid 46363830)
20. R. A. Fromtling J. N. Galgiani M. A. Pfaller A. Espinel-Ingroff K. F. Bartizal M. S. Bartlett B. A. Body C. Frey G. Hall G. D. Roberts F. B. Nolte F. C. Odds M. G. Rinaldi A. M. Sugar K. Villareal 1993 Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts Antimicrob. Agents Chemother. 37 39 45 1:CAS:528:DyaK3sXpslCnuw%3D%3D 8431016
21. Gennaro, A. R., Der Marderosian, A. H., Hanson, G. R., and Medwick, T., Remington: The Science and Practice of Pharmacy. Philadelphia, USA, (2000).
22. P. O. Gubbins B. J. Gurley J. Bowman 1998 Rapid and sensitive high performance liquid chromatographic method for determination of itraconazole and hydroxy-metabolite in human serum J. Pharm. Biomed. Anal. 16 1005 1012 10.1016/S0731-7085(97)00062-9 1:CAS:528:DyaK1cXitFCjt70%3D 9547703 (Pubitemid 28139037)
23. H. A. Hassan A. H. Al-Marzouqi B. Jobe A. A. Hamza G. A. Ramadan 2007 Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide J. Pharm. Biomed. Anal. 45 243 250 10.1016/j.jpba.2007.06.011 1:CAS:528: DC%2BD2sXhtFekur7F 17630246 (Pubitemid 47513421)
24. R. P. Hegde J. L. Rheingold S. Welch C. T. Rhodes 1985 Studies of powder flow using a recording powder flow-meter and measurement of the dynamic angle of repose J. Pharm. Sci. 74 11 15 10.1002/jps.2600740104 1:STN:280: DyaL2M7mtVakug%3D%3D 3981409 (Pubitemid 15155359)
25. A. H. Hikal A. Shibl S. El-Houfy 1982 Determination of sodium fusidate and fusidic acid in dosage forms by high performance liquid chromatography and a microbiological method J. Pharm. Sci. 71 1297 1298 10.1002/jps.2600711130 1:CAS:528:DyaL3sXot1Wm 7175730 (Pubitemid 13230080)
26. J. S. Hostetler J. Heykants K. V. Clemons R. Woestenborghs L. H. Hanson D. A. Stevens 1993 Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: Studies of interpatient variations in concentrations Antimicrob. Agents Chemother. 37 2224 2227 1:CAS:528:DyaK2cXit12rsw%3D%3D 8257148
27. C. D. Hufford M. J. Funderburk J. M. Morgan L. W. Robertson 1975 Two antimicrobial alkaloids from heartwood of Liriodendron tulipifera L J. Pharm. Sci. 64 789 792 10.1002/jps.2600640512 1:CAS:528:DyaE2MXksFeruro%3D 807704
28. C.-C. Hwang W.-C. Lee 2001 Chromatographic resolution of the enantiomers of phenylpropanolamine by using molecularly imprinted polymer as the stationary phase J. Chromatogr. B Biomed. Sci. Appl. 765 45 53 10.1016/S0378-4347(01)00397- 8 1:CAS:528:DC%2BD3MXot1OhtrY%3D 11817309 (Pubitemid 33055807)
29. J. Y. Jung S. D. Yoo S. H. Lee K. H. Kim D. S. Yoon K. H. Lee 1999 Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique Int. J. Pharm. 187 209 218 10.1016/S0378-5173(99)00191-X 1:CAS:528:DyaK1MXmt1Sgsbk%3D 10502627 (Pubitemid 29443901)
30. K. A. Khan 1975 The concept of dissolution efficiency J. Pharm. Pharmacol. 27 48 49 1:CAS:528:DyaE2MXhsVCru7o%3D 235616
31. T. Loftsson M. E. Brewster 1996 Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization J. Pharm. Sci. 85 1017 1025 10.1021/js950534b 1:CAS:528:DyaK28XlsFSrsr4%3D 8897265 (Pubitemid 26338912)
32. A. Miro F. Quaglia L. Giannini B. Cappello M. I. La Rotonda 2006 Drug/cyclodextrin solid systems in designing hydrophilic matrices: A strategy to modulate drug delivery rate Curr. Drug Deliv. 3 373 378 10.2174/ 156720106778558994 1:CAS:528:DC%2BD28XhtVChtb%2FP 17076639 (Pubitemid 44534049)
33. K. Miyake T. Irie H. Arima F. Hirayama K. Uekama M. Hirano Y. Okamaoto 1999 Characterization of itraconazole/ 2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution Int. J. Pharm. 179 237 245 10.1016/S0378-5173(98)00393-7 1:CAS:528:DyaK1MXhsVensbg%3D 10053216 (Pubitemid 29131433)
34. P. Mura G. Bettinetti F. Melani A. Manderioli 1995 Interaction between naproxen and chemically modified β-cyclodextrins in the liquid and solid state Eur. J. Pharm. Sci. 3 347 355 10.1016/0928-0987(95)00025-X 1:CAS:528:DyaK2MXpvVyqtbY%3D
35. P. Mura M. T. Faucci G. P. Bettinetti 2001 The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β- cyclodextrin Eur. J. Pharm. Sci. 13 187 194 10.1016/S0928-0987(01)00093-8 1:CAS:528:DC%2BD3MXisF2qs7Y%3D 11297903 (Pubitemid 32288788)
36. T. K. Ng R. C. Chan F. A. Adeyemi-Doro S. W. Cheung A. F. Cheng 1996 Rapid high performance liquid chromatographic assay for antifungal agents in human sera J. Antimicrob. Chemother. 37 465 472 10.1093/jac/37.3.465 1:CAS:528:DyaK28XitVamu7w%3D 9182103 (Pubitemid 26116961)
37. J. Peeters P. Neeskens J. P. Tollenaere P. van Remoortere M. E. Brewster 2002 Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7 J. Pharm. Sci. 91 1414 1422 10.1002/jps.10126 1:CAS:528:DC%2BD38XktlWrsrc%3D 12115841 (Pubitemid 34633957)
38. S. L. Raghavan K. Schuessel A. Davis J. Hadgraft 2003 Formation and stabilization of triclosan colloidal suspension using supersaturated systems Int. J. Pharm. 261 153 158 10.1016/S0378-5173(03)00299-0 1:CAS:528: DC%2BD3sXls1SqsL8%3D 12878404 (Pubitemid 36962753)
39. V. M. Rao M. Nerurkar S. Pinnamaneni F. Rinaldi K. Raghavan 2006 Co-solubilization of poorly soluble drugs by micellization and complexation Int. J. Pharm. 319 98 106 10.1016/j.ijpharm.2006.03.042 1:CAS:528: DC%2BD28XmvFKnsLg%3D 16765542 (Pubitemid 44051807)
40. Reeves, D. S., Wise, R., Andrews, J. M., and White, L. O., Clinical Antimicrobial Assays. Oxford, (1999).
41. N. Rodriguez-Hornedo D. Murphy 1999 Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems J. Pharm. Sci. 88 651 660 10.1021/js980490h 1:CAS:528:DyaK1MXjtVyis7Y%3D 10393562 (Pubitemid 29325991)
42. A. T. Serajuddin 1999 Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 88 1058 1066 10.1021/js980403l 1:CAS:528:DyaK1MXltl2jtbk%3D 10514356 (Pubitemid 29480600)
43. A. M. Shibl A. F. Tawfik S. El-Houfy F. J. Al-Shammary 1991 Determination of lomefloxacin in biological fluids by high performance liquid chromatography and a microbioloical method J. Clin. Pharm. Ther. 16 353 359 10.1111/j.1365-2710.1991.tb00325.x 1:CAS:528:DyaK38XltVOgsQ%3D%3D 1661289
44. S. Y. Shim C. W. Ji H. Sah E. S. Park B. J. Lee 2006 Characterization of itraconazole semisolid dosage forms prepared by hot melt technique Arch. Pharm. Res. 29 1055 1060 10.1007/BF02969291 1:CAS:528:DC%2BD2sXpt1A%3D 17146976
45. K. Six T. Daems J. de Hoon A. Van Hecken M. Depre M. P. Bouche P. Prinsen G. Verreck J. Peeters M. E. Brewster G. van den Mooter 2005 Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion Eur. J. Pharm. Sci. 24 179 186 10.1016/j.ejps.2004.10.005 1:CAS:528:DC%2BD2MXmsVKhsQ%3D%3D 15661489 (Pubitemid 40127548)
46. R. G. Strickley 2004 Solubilizing excipients in oral and liquid formulations Pharm. Res. 21 201 230 10.1023/B:PHAM.0000016235.32639.23 1:CAS:528:DC%2BD2cXhtlWqt7o%3D 15032302 (Pubitemid 38221966)
47. Truant, A. L., Manual of Commercial Methods in Clinical Microbiology. Virginia, USA, (2002).
48. M. Valero B.I. Pérez-Revuelta L. J. RodrÍguez 2003 Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex Int. J. Pharm. 253 97 110 10.1016/S0378-5173(02)00664-6 1:CAS:528:DC%2BD3sXht1Wmsbs%3D 12593941 (Pubitemid 36197835)
49. H. van Doorne E. H. Bosch 1991 Stability and in vitro activity of nystatin and its γ-cyclodextrin complex against Candida albicans Int. J. Pharm. 73 43 49 10.1016/0378-5173(91)90099-A
50. K. Venkateswarlu D. W. Denning S. L. Kelly 1997 In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei J. Antimicrob. Chemother. 39 731 736 10.1093/jac/39.6.731 1:CAS:528:DyaK2sXksFWqsL8%3D 9222042 (Pubitemid 27296413)
51. D. W. Warnock A. Turner J. Burke 1988 Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole J. Antimicrob. Chemother. 21 93 100 10.1093/jac/21.1.93 1:CAS:528:DyaL1cXhtVGrtL4%3D 2833490